Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Nicola Fusco, Elham Sajjadi, Konstantinos Venetis, et al.
Genes (2020) Vol. 11, Iss. 7, pp. 719-719
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target Therapy
Ioana-Stefania Bostan, Mirela Mihăilă, Viviana Roman, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2027-2027
Open Access | Times Cited: 5
Capivasertib enhances chimeric antigen receptor T cell activity in preclinical models of B-cell lymphoma
Hui-Ju Hsieh, Ryan Urak, Mary C. Clark, et al.
Molecular Therapy — Methods & Clinical Development (2025) Vol. 33, Iss. 1, pp. 101421-101421
Open Access
The Impact of miR-141 Overexpression on Apoptosis and Proliferation in Tscca and Tca8113 Cell Lines
Tao Huang, Bo Shao, Zhongcheng Gong
Journal of Stomatology Oral and Maxillofacial Surgery (2025), pp. 102270-102270
Closed Access
Next-generation sequencing for PTEN testing in HR+/HER2˗ metastatic breast cancer
Nicola Fusco, Umberto Malapelle
Critical Reviews in Oncology/Hematology (2025), pp. 104626-104626
Closed Access
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins
Ishaar P. Ganesan, Hiroaki Kiyokawa
Cancers (2025) Vol. 17, Iss. 4, pp. 626-626
Open Access
The Potential of Pharmacological Intervention Targeting NEDD4 in Glioma
Amjad Z. Alrosan, Enaam Al Momany, Ghaith B. Heilat, et al.
Heliyon (2025), pp. e42996-e42996
Open Access
Artesunate Suppresses the Migration and Invasion of Thyroid Cancer Cells via Upregulating PTEN to Block M2 Polarization of Tumor‐Associated Macrophages
Zhiwei Xu, Xiuping Li, Daoping Zhuang
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 3
Closed Access
Dual Targeting of Pim and PI3 Kinases in Mature T‐Cell Lymphoma
Melanie Lohrberg, Maike Heber, Laure Nicolas Annick Ries, et al.
European Journal Of Haematology (2025)
Open Access
Cytotoxic Effect of Escitalopram/Etoposide Combination on Etoposide-Resistant Lung Cancer
Serap Özkaya Gül, B. Şimşek, Fidan Yıldız, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 531-531
Open Access
In Silico Discovery of a Novel Natural Product Targeting PI3Kα for the Treatment of Head and Neck Squamous Cell Carcinoma
Wenqing Jia, Xian‐Chao Cheng
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3565-3565
Open Access
Comprehensive genomic profiling reveals a unique genomic landscape in solid tumors in an Indian cancer cohort of 1000 patients: a single institutional experience
Mithua Ghosh, Sheela Mysore Lingaraju, ChagamreddyMurali Krishna, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
Elham Sajjadi, Konstantinos Venetis, Cristian Scatena, et al.
ecancermedicalscience (2020) Vol. 14
Open Access | Times Cited: 33
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology
Carmen Criscitiello, Elena Guerini‐Rocco, Giulia Viale, et al.
Anti-Cancer Agents in Medicinal Chemistry (2021) Vol. 22, Iss. 4, pp. 787-800
Open Access | Times Cited: 30
Circulating Tumor DNA Dynamics as Prognostic Markers in Locally Advanced and Metastatic Esophageal Squamous Cell Carcinoma
Hoi Yan Ng, Josephine Mun Yee Ko, Ka On Lam, et al.
JAMA Surgery (2023) Vol. 158, Iss. 11, pp. 1141-1141
Open Access | Times Cited: 12
Pancreatic Neuroendocrine Tumors: Signaling Pathways and Epigenetic Regulation
Zena Saleh, Matthew C. Moccia, Zachary Ladd, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1331-1331
Open Access | Times Cited: 4
Golgi apparatus targeted therapy in cancer: Are we there yet?
Zheng Yang Lee, Wen Hwei Lee, Jing Sheng Lim, et al.
Life Sciences (2024) Vol. 352, pp. 122868-122868
Closed Access | Times Cited: 4
Investigation of GSTP1 and PTEN gene polymorphisms and their association with susceptibility to colorectal cancer
Durr-e-Shahwar, Hina Zubair, Muhammad Kashif Raza, et al.
Radiology and Oncology (2025)
Open Access
Perspectives in MicroRNA Therapeutics for Cystic Fibrosis
Alessia Finotti, Roberto Gambari
Non-Coding RNA (2025) Vol. 11, Iss. 1, pp. 3-3
Open Access
PTEN-Mediated Resistance in Cancer: From Foundation to Future Therapies
Muhammad Tufail
Toxicology Reports (2025) Vol. 14, pp. 101987-101987
Open Access
PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics
Glena Travis, Eileen McGowan, Ann M. Simpson, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4954-4954
Open Access | Times Cited: 10
Efficient Bioinspired Feature Selection and Machine Learning Based Framework Using Omics Data and Biological Knowledge Data Bases in Cancer Clinical Endpoint Prediction
Imène Zenbout, Abdelkrim Bouramoul, Souham Meshoul, et al.
IEEE Access (2023) Vol. 11, pp. 2674-2699
Open Access | Times Cited: 9
Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy
Atif Khurshid Wani, Reena Singh, Nahid Akhtar, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 16, pp. 1496-1520
Closed Access | Times Cited: 3
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling
Elham Sajjadi, Konstantinos Venetis, Roberto Piciotti, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Comprehensive analysis of PTEN‐related ceRNA network revealing the key pathways WDFY3‐AS2 ‐ miR‐21‐5p/miR‐221‐3p/miR‐222‐3p ‐ TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma
Xi-Shan Zhou, Guofeng Liu, Mo Xu, et al.
Molecular Carcinogenesis (2022) Vol. 61, Iss. 5, pp. 508-523
Closed Access | Times Cited: 14
Comparing Redox and Intracellular Signalling Responses to Cold Plasma in Wound Healing and Cancer
Adrian I. Abdo, Zlatko Kopecki
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4885-4923
Open Access | Times Cited: 2

Scroll to top